KNSA
Kiniksa Pharmaceuticals Ltd.
$36.08
+$0.66(+1.86%)
62
Overall
35
Value
90
Tech
--
Quality
Market Cap
$2.62B
Volume
267.06K
52W Range
$17.82 - $37.34
Target Price
$43.00
Key Metrics Overview
| Market Cap | $2.62B | P/E Ratio | 35.03 |
| 52W High | $37.34 | 52W Low | $17.82 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 36.1% | 52W Position | 93.5% |
| Overall Score | 62 | Value Score | 35 |
| Quality Score | -- | Technical Score | 90 |
Growth Analysis
| EPS Current Est | $1.03 | EPS Next Est | $1.6 |
| EPS Growth Est | +55.3% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $36.08 | +1.9% | 267.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW